Marksans Pharma Limited submits Transcript of Investors/analysts meet on Q2 FY26 Unaudited Financial Results held on November 14 2025 at 05:00 pm.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]